Results 231 to 240 of about 5,297,540 (313)

Can radiotherapy be omitted in T1-2N1 breast cancer patients after mastectomy without neoadjuvant therapy? [PDF]

Front Oncol
Hou J, Qian S, Liao C, Wu C, Zhang X, Gao Y.   +5 more
europepmc   +1 more source

Ovarian Cancer: Epidemiology, Disease Mechanisms, New Diagnosis and Treatment Strategies, and Research Directions

iNew Medicine, EarlyView.
ABSTRACT Ovarian cancer (OC) continues to be the deadliest gynecological malignancy and a significant cause of cancer‐related mortality among women worldwide. Standard treatment strategies typically entail platinum‐based chemotherapy in conjunction with cytoreductive surgery.
Zunera Khalid, Weirong Fan, Farah Nazir, Yixiang Xing, Tengchuan Jin   +4 more
wiley   +1 more source

Status of Lymph Node Metastasis and Efficacy of Lymph Node Dissection Along the Superior Mesenteric Artery in Pancreatic Head Cancer: Clinicopathological Analysis of Patients Undergoing Pancreatoduodenectomy With Circumferential Lymph Nodes Dissection Along the Superior Mesenteric Artery

Journal of Hepato-Biliary-Pancreatic Sciences, EarlyView.
ABSTRACT Background Between 2002 and 2013, we performed pancreatoduodenectomy (PD) with combined resection of the superior mesenteric artery (SMA) (PD‐SMAR) to treat locally advanced pancreatic head cancer (PHC). Since 2011, we have performed PD with circumferential lymph node dissection along the SMA (PD‐CLDS), in which we dissected lymph nodes all ...
Isamu Makino, Hirohisa Kitagawa, Ryohei Takei, Kaichiro Kato, Satoshi Takada, Mitsuyoshi Okazaki, Yasuhito Iwao, Shinichi Nakanuma, Tetsuo Ohta, Shintaro Yagi   +9 more
wiley   +1 more source

Prognostic value of tumor deposits and their different response to neoadjuvant therapy in locally advanced rectal cancer. [PDF]

PLoS One
Zhou D, Zhou J, Hu B, Yu Y, Bian Y, Yang C, Bai Y, Chen H.   +7 more
europepmc   +1 more source

Incidence and Determinants of Steatotic Liver Disease after Pancreaticoduodenectomy: A Systematic Review and Meta‐Analysis

Journal of Hepato-Biliary-Pancreatic Sciences, EarlyView.
ABSTRACT Background Steatotic liver disease (SLD) is an unrecognized complication after pancreaticoduodenectomy (PD) and may affect nutrition and long‐term recovery. This meta‐analysis estimated the incidence of SLD after PD and identified its clinical and surgical risk factors.
Ronnakorn Kongsakon, Wasit Wongtrakul, Khemajira Karaketklang, Nonthalee Pausawasdi, Phunchai Charatcharoenwitthaya   +4 more
wiley   +1 more source

Comparative Effectiveness and Modality-Dependent Prognostic Value of Pathological Response Following Neoadjuvant Therapy for Locally Advanced Gastric Cancer. [PDF]

Cancer Med
Zhu Y, Chen Z, Jo M, Feng S, Zeng Y, Chen X, Guo J, Ding C, Jin Y, Qiu H.   +9 more
europepmc   +1 more source

Neoadjuvant Chemotherapy in Triple Negative Breast Cancer: A Systematic Review of Breast and Node Pathologic Response

Journal of Surgical Oncology, EarlyView.
ABSTRACT Introduction Pathological complete response (pCR) after neoadjuvant chemotherapy is associated with improved prognosis in patients with triple‐negative breast cancer (TNBC). Differences in pathological response rates between the breast and axillary lymph nodes have prompted interest in understanding response patterns that may, in the future ...
Milena Martello Cristófalo, Jonathan Yugo Maesaka, Deise Azevedo Pereira, Gabriela Bezerra Nóbrega, Yedda Nunes Reis, José Maria Soares Júnior, Edmund Chada Baracat, José Roberto Filassi   +7 more
wiley   +1 more source

Boost Approaches in Patients Undergoing Postoperative Radiotherapy

Journal of Surgical Oncology, EarlyView.
ABSTRACT The use of breast conservation surgery for early‐stage breast cancer is common, and adjuvant radiotherapy is often recommended to reduce the risk of ipsilateral breast tumor recurrence. Historical trials have used sequential boost techniques with favorable outcomes with reduction in local recurrence and acceptable cosmetic outcomes.
Abigail Pepin, Neil D. Almeida, Simon Fung‐Kee‐Fung, Megan Kassick, Neil K. Taunk, Gary M. Freedman   +5 more
wiley   +1 more source

Predictive factors for histological response to neoadjuvant therapy in gastric adenocarcinomas. [PDF]

Arq Bras Cir Dig
Bacha D, Boudrigua N, Mallek I, Chammem S, Attia M, Gharbi L, Lahmar A, Ben-Slama S.   +7 more
europepmc   +1 more source